Lexeo Therapeutics, Inc. Common Stock
← Back to LXEO Overview

Lexeo Therapeutics, Inc. Common Stock (LXEO)

Revenue & Top-Line Growth

Latest Revenue

$-

Financial Fundamentals

LXEOQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B0.00B
2025-12-310.00B0.00B
2025-09-300.00B0.00B
2025-06-300.00B0.00B
2025-03-310.00B0.00B
2024-12-310.00B0.00B
2024-09-300.00B0.00B
2024-06-300.00B0.00B
2024-03-310.00B0.00B
2023-12-310.00B0.00B
2023-09-300.00B0.00B
2023-06-300.00B0.00B
2023-03-310.00B0.00B
2022-12-310.00B0.00B
2022-09-300.00B+1335.1%0.00B
2022-06-300.00B-56.8%0.00B
2022-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.00B
20240.00B
20230.00B
20220.00B-60.5%
20210.00B+219.6%
20200.00B